The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 28, 2021
Filed:
Nov. 15, 2017
Applicant:
Janssen Biotech, Inc., Horsham, PA (US);
Inventors:
Dennis Fitzgerald, Spring House, PA (US);
Newman Yeilding, Spring House, PA (US);
Jay Siegel, Chevy Chase, MD (US);
Assignee:
JANSSEN BIOTECH, INC., Horsham, PA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/24 (2006.01); A61K 9/00 (2006.01); G01N 33/00 (2006.01); A61P 17/06 (2006.01); A61K 31/519 (2006.01); A61K 45/06 (2006.01); C07K 16/28 (2006.01); A61K 47/22 (2006.01); A61K 47/26 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/244 (2013.01); A61K 9/0019 (2013.01); A61K 31/519 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61P 17/06 (2018.01); C07K 16/28 (2013.01); C07K 16/2887 (2013.01); G01N 33/00 (2013.01); A61K 47/22 (2013.01); A61K 47/26 (2013.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01); C07K 2317/21 (2013.01);
Abstract
A method of treating psoriasis in a patient previously treated with and determined to be an inadequate responder to an IL-12/23p40 antibody by administering an IL-23 specific antibody, e.g., guselkumab, in a safe and effective amount and the patient achieves PASI75, PASI90, PASI100 or IGA 0 or 1 score as measured 16, 24, 32, 40 and 48 weeks after initial treatment.